Management of acute stroke in patients taking novel oral anticoagulants
© 2014 The Authors. International Journal of Stroke published by John Wiley & Sons Ltd on behalf of World Stroke Organization..
Each year, 1·0-2·0% of individuals with atrial fibrillation and 0·1-0·2% of those with venous thromboembolism who are receiving one of the novel oral anticoagulants (dabigatran, rivaroxaban, or apixaban) can be expected to experience an acute ischemic stroke. Additionally, 0·2-0·5% of individuals with atrial fibrillation who are receiving one of the novel oral anticoagulants can be expected to experience an intracranial hemorrhage. This opinion piece addresses the current literature and offers practical approaches to the management of patients receiving novel oral anticoagulants who present with an ischemic or hemorrhagic stroke. Specifically, we discuss the role of thrombolysis in anticoagulated patients with acute ischemic stroke and factors to consider concerning restarting anticoagulation after acute ischemic and hemorrhagic stroke.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
International journal of stroke : official journal of the International Stroke Society - 9(2014), 5 vom: 18. Juli, Seite 627-32 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hankey, Graeme J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acute stroke |
|---|
| Anmerkungen: |
Date Completed 23.01.2015 Date Revised 21.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/ijs.12295 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM238817709 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM238817709 | ||
| 003 | DE-627 | ||
| 005 | 20231224114618.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ijs.12295 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0796.xml |
| 035 | |a (DE-627)NLM238817709 | ||
| 035 | |a (NLM)24891030 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hankey, Graeme J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Management of acute stroke in patients taking novel oral anticoagulants |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.01.2015 | ||
| 500 | |a Date Revised 21.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2014 The Authors. International Journal of Stroke published by John Wiley & Sons Ltd on behalf of World Stroke Organization. | ||
| 520 | |a Each year, 1·0-2·0% of individuals with atrial fibrillation and 0·1-0·2% of those with venous thromboembolism who are receiving one of the novel oral anticoagulants (dabigatran, rivaroxaban, or apixaban) can be expected to experience an acute ischemic stroke. Additionally, 0·2-0·5% of individuals with atrial fibrillation who are receiving one of the novel oral anticoagulants can be expected to experience an intracranial hemorrhage. This opinion piece addresses the current literature and offers practical approaches to the management of patients receiving novel oral anticoagulants who present with an ischemic or hemorrhagic stroke. Specifically, we discuss the role of thrombolysis in anticoagulated patients with acute ischemic stroke and factors to consider concerning restarting anticoagulation after acute ischemic and hemorrhagic stroke | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a acute stroke | |
| 650 | 4 | |a anticoagulants | |
| 650 | 4 | |a intracerebral hemorrhage | |
| 650 | 4 | |a secondary prevention | |
| 650 | 4 | |a thrombolytic therapy | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 700 | 1 | |a Norrving, Bo |e verfasserin |4 aut | |
| 700 | 1 | |a Hacke, Werner |e verfasserin |4 aut | |
| 700 | 1 | |a Steiner, Thorsten |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of stroke : official journal of the International Stroke Society |d 2006 |g 9(2014), 5 vom: 18. Juli, Seite 627-32 |w (DE-627)NLM181612585 |x 1747-4949 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2014 |g number:5 |g day:18 |g month:07 |g pages:627-32 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/ijs.12295 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2014 |e 5 |b 18 |c 07 |h 627-32 | ||